卡托普利和缬沙坦对兔动脉粥样硬化斑块中血管紧张素Ⅱ及纤溶酶原激活物抑制剂1表达的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

山西省自然基金项目(20041114)资助


Effects of Captopril and Valsartan on the Expression of Angiotensin Ⅱ and Plasminogen Activator Inhibitor-1 in Aortic Plaques of Atherosclerotic Rabbits
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的观察兔动脉粥样硬化斑块局部血管紧张素Ⅱ和纤溶酶原激活物抑制物1的表达水平,并观察卡托普利和缬沙坦对其的影响。方法雄性健康新西兰兔随机分为高脂饮食组、卡托普利组、缬沙坦组和正常对照组。饲养10周后,取动脉血用发色底物法测定血浆纤溶酶原激活物抑制物1活性,放射免疫法测定血浆血管紧张素Ⅱ含量;取主动脉组织作病理形态学观察,免疫组织化学方法观察动脉粥样硬化斑块中血管紧张素Ⅱ及纤溶酶原激活物抑制物1的表达。结果与正常对照组相比,高脂饮食组血浆血管紧张素Ⅱ含量显著增高(494.86±67.98 ng/L比44.21±18.34 ng/L,p<0.01),血浆纤溶酶原激活物抑制物1活性显著提高(9.38±1.55 kAU/L比6.67±0.47 kAU/L,p<0.01),动脉粥样硬化斑块中血管紧张素Ⅱ及纤溶酶原激活物抑制物1阳性表达显著增高(46.97%±14.32%比4.17%±1.01%和48.50%±13.46%比1.33%±0.52%,p<0.01);与高脂饮食组相比,卡托普利组和缬沙坦组血浆纤溶酶原激活物抑制物1活性明显降低(7.23±0.46 kAU/L和7.42±0.59 kAU/L比9.38±1.55 kAU/L,p<0.05),斑块中血管紧张素Ⅱ阳性表达显著降低(26.30%±5.00%和27.83%±7.30%比46.97%±14.32%,p<0.05),斑块中纤溶酶原激活物抑制物1阳性表达显著降低(20.37%±8.23%和22.50%±7.06%比48.50%±13.46%,p<0.05)。斑块中纤溶酶原激活物抑制物1表达与血管紧张素Ⅱ表达呈正相关(r=0.796,p<0.01)。结论在高脂饮食所致动脉粥样硬化斑块中血管紧张素Ⅱ和纤溶酶原激活物抑制物1的表达增加,且二者呈正相关;卡托普利和缬沙坦减轻动脉粥样硬化斑块中血管紧张素Ⅱ和纤溶酶原激活物抑制物1的表达。

    Abstract:

    Aim To observe the expression of angiotensin Ⅱ(AngⅡ) and plasminogen activator inhibitor-1(PAI-1) in rabbits atherosclerotic plaques,and to study the inhibiting efficiency of captopril and valsartan. Methods Male New Zealand white rabbits were randomly divided into four groups: cholesterol group,captopril group,valsartan group and control group.After feeding 10 weeks,plasma PAI-1 activity was evaluated by spectrphotometric assy,plasma AngⅡ level was measured with competitive radioimmunoassays.The expression of AngⅡ and PAI-1 in atherosclerotic plaques were observed by immunohistochenistry measure. Results In cholesterol group,plasma AngⅡ level and plasma PAI-1 activity were increased significantly compared with control group(p<0.01),and the percent of positive cells of AngⅡ and PAI-1 in atherosclerotic plaques were higher compared with control group(46.97%±14.32% vs 4.17%±1.01% and 48.5%±13.46% vs 1.33%±0.52% respectively,p<0.01).Captopril and valsartan significantly reduced plasma AngⅡ level and PAI-1 activity compared with cholesterol group(p<0.05).Also captopril and valsartan markedly decreased the percent of AngⅡ positive and PAI-1 positive cells in atherosclerotic plaques compared with cholesterol group(26.30%±5.00% vs 46.97%±14.32% and 20.37%±(8.23%) vs 48.50%±13.46%,p<0.05 in captopril group;27.83%±7.30% vs 46.97%±14.32% and 22.50%±(7.06%) vs 48.50%±13.46%,p<0.05 in valsartan group).The expression of PAI-1 were positively correlated with the expression of AngⅡ in atherosclerotic plaques(r=0.796,p<0.01). Conclusion The expression of AngⅡ and PAI-1 in atherosclerotic plaques were increased,there was significant correlation between the expression of PAI-1 and AngⅡ,both captopril and valsartan have the efficiency of inhibiting the expression of Ang Ⅱ and PAI-1 in plaques of rabbit atherosclerosis.

    参考文献
    相似文献
    引证文献
引用本文

鹿育萨,雷新宇,黄淑田,白春林,李建民.卡托普利和缬沙坦对兔动脉粥样硬化斑块中血管紧张素Ⅱ及纤溶酶原激活物抑制剂1表达的影响[J].中国动脉硬化杂志,2006,14(6):479~482.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2005-06-13
  • 最后修改日期:2006-05-15
  • 录用日期:
  • 在线发布日期: